Background: Circulating levels of the pro-inflammatory cytokine interleukin-6 (IL-6) levels are elevated in older adults, but mechanisms are unclear. In the current study, we used an untargeted metabolomic approach to develop an improved understanding about mechanisms related to circulating IL-6 in older adults. Methods: Serum IL-6 values were log-transformed to normalize its distribution. Multivariable-adjusted linear regression was used to examine the association between 324 serum metabolites with log IL-6. Backward elimination linear regression was used to develop a metabolite predictor set representative of log IL-6. Results: Thirty-six metabolites were significantly associated (p < 0.05 and q < 0.30) with log IL-6 in 73 older adults (average age, 78 years). Metabolites related to tryptophan metabolism (kynurenine, 3-indoxyl sulfate, indoleacetate, indolepropionate, C-glycosyltryptophan), infectious burden (C-glycosyltryptophan, N 6 -carbamoylthreonyladenosine, 1-methylurate, N-formylmethionine, N 1 -methyladenosine, 3-indoxyl sulfate, bilirubin (E,E), indoleacetate, γ-CEHC, N-acetylneuraminate), aryl hydrocarbon receptor activation and cytochrome P450 (CYP) 1A expression (kynurenine, 3-indoxyl sulfate, indoleacetate, N 6 -carbamoylthreonyladenosine, bilirubin, 1-methylurate) were positively associated, whereas metabolites related to CYP-mediated ω-oxidation (adipate, 8-hydroxyoctanoate, azelate, sebacate, undecanedioate, γ-CEHC), and peroxisome proliferator activated receptor-alpha (PPAR-α) activation (13 + 9-HODE, bilirubin, 5-oxoproline, cholesterol, glycerate, uridine) were negatively associated with log IL-6. The use of backward elimination regression identified tyrosine, cysteine, uridine, bilirubin, N-formylmethionine, indoleacetate, and 3-indoxyl sulfate to collectively explain 51% of the variance inherent in log IL-6. Conclusions: These data suggest roles for tryptophan metabolism, infectious burden, activation of host defense, and detoxification through CYP1A-mediated pathways in mechanisms related to elevated inflammation, whereas CYP-mediated ω-oxidation and PPAR-α activation may be related to decreased inflammation in older adults.
Interleukin-6 (IL-6) is a pro-inflammatory cytokine that is secreted from activated monocytes, macrophages, fibroblasts, adipocytes, myocytes, and endothelial cells in response to various stimuli, including bacterial endotoxins, physical exercise, and oxidative stress (1) . IL-6 levels are often undetectable in young individuals but increase with advancing age (2) . In older adults, elevated levels of IL-6 are associated with decreased physical function, frailty, disability, cognitive decline, obesity, diabetes, cardiovascular disease, cancer, and an increased mortality risk (3) (4) (5) (6) (7) (8) (9) (10) (11) . Because older adults (70+ years) are the fastest growing subpopulation in the world (12) , the development of an improved understanding about mechanisms related to circulating levels of IL-6 will be important for addressing the public health priority of healthy aging.
One approach that can be used to elucidate mechanisms related to circulating levels of IL-6 is mass spectrometry (MS)-based metabolomics, which (when an untargeted approach is used) aims to characterize and quantify all of the metabolites in a biological sample, thereby providing an analytical description of complex metabolic processes (13) . Metabolomic profiling has been previously used to develop an improved understanding about inflammation-related diseases, including rheumatoid arthritis (14) and inflammatory bowel disease (15) . However, metabolomic-based studies aimed at investigating metabolites and potential mechanisms related to inflammation in older adults are limited. For example, although inflammatory markers and metabolites that differentiate centenarians from elderly and young subjects have been reported (16) , associations between metabolites with inflammatory markers were not determined. Therefore, the goal of the current study was to develop an improved understanding about mechanisms related to inflammation by characterizing the association between circulating MS metabolites with serum IL-6 in older adults.
Materials and Methods

Participants
Metabolomic and IL-6 analyses were performed on serum samples obtained from the 73 older adults of Chale et al. (17) . All participants were required to be sedentary, defined as the absence of structured exercise during the previous 6 months. The study was approved by the Tufts University Health Sciences Campus Institutional Review Board.
Measurement of IL-6
Serum levels of IL-6 were measured using a quantikine high-sensitivity ELISA kit (R&D Systems, Stillwater, MN), using reagents, calibrators, and standard operating procedures as specified by the manufacturer.
Metabolomic Analysis
Ten millilitres of blood was collected under standardized conditions between 8 and 10 am, and following an overnight fast. Following collection, blood was allowed to clot for 1 hour at room temperature and was centrifuged at 2,135g for 10 minutes at 4°C. Serum was derived by removing the supernatant and was stored in 1 mL aliquots at −80°C, prior to analysis.
Serum metabolomic data acquisition was performed by Metabolon Inc. (Research Triangle Park, NC), as previously reported (18) . Small-molecule metabolites were extracted from serum, and the reconstituted extracts were resolved using untargeted mass spectrometry platforms, including ultrahigh-performance liquid chromatography/tandem mass spectrometry (UHPLC/MS/MS) and gas chromatography/mass spectrometry (GC/MS). Chromatographic separation of all ions in each sample was followed by full-scan mass spectra to record retention time and molecular weight (m/z) of all detectable ions present in the samples. Library matching of these ions to Metabolon's reference library of standards (2,000 authentic standards, plus thousands of additional library entries of unknown biochemicals based on unique characteristics of retention time, nominal mass, and fragmentation pattern) was then performed. The identity of metabolites was determined by matching the combination of chromatographic retention index and mass spectra signatures compared to the reference library entries (18) . Using this technique, data for 324 metabolites were obtained, with the full list reported by Evans et al. (18) . The median relative standard deviation for the internal standards (measurement of instrument variability) was 6%, whereas the relative standard deviation for endogenous biochemicals (measurement of the total process variability) was 12%.
After a compound is identified in a sample, one of the characteristic and stronger ions is used to determine a relative concentration of that compound in each sample, thereby assuring that the compound will be represented only once in statistical analyses. Relative quantitation was based on peak integration and was expressed as scaled intensity. Following peak identification and quality control filtering, integrated peak ion counts for each compound in each sample were normalized to correct for variation resulting from instrument interday tuning differences. Normalized peak area counts were divided the median value for each run-day, therefore setting the medians equal to 1 for each day's run. Median scaled data were natural logtransformed prior to statistical analysis. Use of this method removes the variation that exists between each instrument run-day while the variation that exists across experimental samples remains (19) .
Statistics
SAS Enterprise Guide 5.1 was used for all statistical analyses. IL-6 values were not normally distributed (Shapiro-Wilk W = 0.80, p < 0.0001). Log transformation significantly improved the normality of the IL-6 distribution (Shapiro-Wilk W = 0.98, p = 0.42). Sex, age, and body mass index (BMI)-adjusted linear regression was then used to examine the association between log IL-6 with circulating metabolites. Each model included sex, age, BMI, and individual metabolites. To account for multiple comparisons, false discovery rates (20) were computed with use of the q-value method (21) . Statistical significance was set at p < 0.05 and q < 0.30, as reported by Meyers et al. (22) . A q value of 0.30 indicates that the result is likely to be valid 7 out of 10 times, which we suggest is reasonable in the setting of exploratory discovery. q-Values were computed based on 373 p-values, including 324 associations between metabolites with log IL-6, 35 associations between significant log IL-6 metabolites with the kynurenine/tryptophan (KYN/TRYP) ratio, 11 associations between dicarboxylic fatty acid (DC FA)/cognate fatty acid ratios with log IL-6, and associations between KYN/TRYP, β-alanine/ aspartate and acetoacetate/1,2 propanediol ratios with log IL-6.
To determine the KYN/TRYP, β-alanine/aspartate, acetoacetate/1,2 propanediol, and DC/cognate fatty acid ratios, the raw MS values for kynurenine and tryptophan, β-alanine and aspartate, acetoacetate and 1,2 propanediol, DCs and their cognate fatty acids, respectively, were divided, followed by median scaling and natural log transformation. Associations between KYN/TRYP, β-alanine/ aspartate, acetoacetate/1,2 propanediol, or DC/cognate fatty acid ratios with individual metabolites or with log IL-6 were examined with use of sex, age, and BMI-adjusted linear regression.
Backward elimination regression was used to develop a log IL-6 predictive model. Candidate variables for the backward elimination model included sex, age, BMI, and metabolites that were significantly associated (p < 0.05 and q < 0.30) with log IL-6. Statistical significance to be retained in the backward elimination model was set at p < 0.05.
Results
Metabolomic and IL-6 analyses were performed on serum samples obtained from the 73 (43 women, 30 men) overweight older adults (average BMI and age: 27.0 ± 3.2 kg/m 2 , 77.7 ± 3.9 years) of Chale et al. (17) . Prior to log transformation, the median IL-6 value for this cohort was 1.9 pg/mL (interquartile range, 1.4-2.8 pg/mL). These values are similar to the IL-6 interquartile range reported for the 2,339 older adults of the Dynamics of Health, Aging, and Body Composition study (1.3-2.8 pg/mL) (23) , where baseline IL-6 values were associated with significantly increased all-cause mortality risk (24) .
Metabolites Associated With IL-6
Thirty-six metabolites were significantly associated with log IL-6 (Table 1) . Kynurenine, bilirubin (E,E), N-formylmethionine, bilirubin (Z,Z), indolepropionate, N 1 -methyladenosine, tyrosine, acetoacetate, N 6 -carbamoylthreonyladenosine, betaine, β-alanine, γ-carboxyethyl-hydroxychroman (γ-CEHC), C-glycosyltryptophan, 3-indoxyl sulfate, indoleacetate, N-acetylneuraminate, trans-4-hydroxyproline, ADSGEGDFXAEGGGVR, DSGEGDFXAEGGGVR, valine, 1-methylurate, glycodeoxycholate, and cysteine were positively associated, whereas uridine, 1-stearoylglycerophosphoethanolamine, undecanedioate, azelate, γ-glutamylvaline, 13-HODE + 9-HODE, cholesterol, adipate, 1,2-propanediol, 8-hydroxyoctanoate, glycerate, sebacate, and 5-oxoproline were negatively associated with log IL-6. Non-significant associations between serum metabolites with log IL-6 are shown in Supplementary Table 1.
Metabolites Associated With both Log IL-6 and KYN/TRYP Suggest a Role for Infectious Burden on Elevated Inflammation
Identification of associations between kynurenine and four additional tryptophan-related metabolites (indolepropionate, 3-indoxyl sulfate, indoleacetate, C-glycosyltryptophan) with log IL-6 suggests a role for infectious burden on mechanisms related to elevated inflammation in older adults. In support of this, the degradation of tryptophan to form kynurenine is catalyzed by indoleamine-pyrrole 2,3-dioxygenase (25), a protein whose expression is induced by IFN-gamma (IFN-γ). IFN-γ is produced in response to parasitic, viral, and bacterial infection (26) (27) (28) (29) . To investigate the relationship between infectious burden with inflammation, metabolites that were significantly associated with log IL-6 were tested for their association with a marker of IFN-γ, the kynurenine/ tryptophan ratio (KYN/TRYP (30)). KYN/TRYP was significantly associated with log IL-6 (β ± SE, 0.3 ± 0.1; p = 0.01, q = 0.14). Ten metabolites that were significantly associated with log IL-6, including C-glycosyltryptophan, N 6 -carbamoylthreonyladenosine, 1-methylurate, N-formylmethionine, N 1 -methyladenosine, 3-indoxyl sulfate, bilirubin (E,E), indoleacetate, γ-CEHC, and N-acetylneuraminate were additionally associated with KYN/ TRYP ( Table 2) . Associations between metabolites significantly associated with log IL-6 but not with KYN/TRYP are shown in Supplementary Table 2 .
Associations Between Dicarboxylic Fatty Acids (DC FAs) and DC FAs/Cognate FA Ratios With Log IL-6 Suggest a Role for Cytochrome P450-mediated ω-oxidation on Decreased Inflammation
The cytochrome P450 (CYP) proteins CYP4A11 and CYP4B1 utilize ω-oxidation to convert short (C7-C9, via CYP4A) and medium chain (C10-C16, via CYP4B) fatty acids into their corresponding dicarboxylic species (31) . Negative associations between adipate (C6-DC), 8-hydroxyoctanoate (C8-OH, formed during CYP4A-mediated ω-oxidation), azelate (C9 DC), sebacate (C10 DC), and undecanedioate (C11 DC) with log IL-6 suggest a role for CYPmediated ω-oxidation in mechanisms related to decreased IL-6 in older adults. In contrast, CYP4F2 utilizes ω-oxidation to convert γ-tocopherol into γ-CEHC (32), a metabolite that was positively associated with log IL-6. Interestingly, γ-CEHC was negatively associated with thigh muscle cross-sectional area, the fat-free mass index (total lean mass/height 2 ), the short physical performance battery, and leg press one repetition maximum/total lean mass (Supplementary Table 3 ), evidence that suggests a link between γ-CEHC with inflammation, the maintenance of lean and skeletal muscle mass, and physical function in older adults. To further explore the association between ω-oxidation between IL-6, the association between the DC FA/cognate fatty acid ratio for C5, C6, C8, C9, C10, C11, C12, C14, C16, C18, and C8-OH/C8 with log IL-6 was examined. The DC FA/cognate fatty acid ratios for C9, C10, and C11 were significantly associated with log IL-6 (Table 3) .
IL-6 Predictive Modeling
Backward elimination regression was used to develop a log IL-6 predictive model. The combination of tyrosine, cysteine, uridine, bilirubin (E,E), N-formylmethionine, indoleacetate, and 3-indoxyl sulfate was found to explain 51% of variance (adjusted R 2 ) inherent in log IL-6 (Table 4) .
Discussion
The main findings of the current study suggest roles for tryptophan metabolism, infectious burden, aryl hydrocarbon receptor activation, cytochrome P450 (CYP) expression, and PPAR-α activation on mechanisms related to circulating IL-6 in older adults.
Upon first inspection of the thirty-six metabolites that were significantly associated with log IL-6, a role for tryptophan metabolism (kynurenine, indoleacetate, 3-indoxyl sulfate, indolepropionate, C-glycosyltryptophan) was evident. The degradation of tryptophan to form kynurenine is catalyzed by indoleamine-pyrrole 2,3-dioxygenase (IDO) (25) . Tryptophan depletion by IDO serves as a defense mechanism toward invading pathogens by suppressing their proliferation, as tryptophan is an essential amino acid (27) . In addition, IDO expression is induced by IFN-γ, a cytokine that is produced in response to parasitic, viral, and bacterial infection (26) (27) (28) (29) . Collectively, these data suggest a link between tryptophan metabolism with infectious burden and inflammation in older adults. In support of this hypothesis, we identified a significant association between a marker of IFN-γ, the KYN/TRYP ratio (30, 33) , with log IL-6. Furthermore, 10 metabolites that were significantly associated with log IL-6 were additionally associated with KYN/ TRYP. Of these, the intestinal degradation of tryptophan to form indole (the precursor metabolite for the production of 3-indoxyl sulfate) is catalyzed by tryptophanase, which is highly expressed in Escherichia coli (34) , and indoleacetate regulates several aspects of bacterial function that are associated with pathogenicity and motility (35) . Although N-acetylneuraminate, N 1 -methyladenosine, and N-formylmethionine are not derived from tryptophan metabolism, their association with both KYN/TRYP and log IL-6 supports the hypothesis that infectious burden is associated with elevated inflammation in older adults. Binding of Staphylococcus aureus to N-acetylneuraminate promotes its adhesion and invasion into host epithelial cells (36) . N 1 -methyladenosine is found in tRNA (37) , where its presence is required for the termination of viral replication (38) . N-formylmethionine is a potent chemoattractant for neutrophils, which are involved in the host's resistance to infection (39) .
Associations between glycodeoxycholate, ADSGEGDFXAEGGGVR, DSGEGDFXAEGGGVR, β-alanine, acetoacetate, and 1,2 propanediol with log IL-6 provide additional support for the hypothesis that infectious burden is related to elevated inflammation in older adults. Glycodeoxycholate, ADSGEGDFXAEGGGVR, and DSGEGDFXAEGGGVR (fibrinogen cleavage peptides) are increased during infection (40) (41) (42) . Fibrinogen cleavage products have antimicrobial activity and have been proposed to be a part of the early innate immune system, whose goal is the rapid neutralization of invading pathogens (43) . β-Alanine is found in the colonic lumen from conventional, but not germ-free mice (44) , and can be produced from aspartate by E coli (45) . Interestingly, the β-alanine/aspartate ratio was significantly associated with log IL-6 (β ± SE, 0.1 ± 0.0; p = 0.009, q = 0.14), a finding that may link E coli overgrowth with inflammation in older adults. The conversion of acetoacetate to 1,2 propanediol proceeds through CYP2E1, a protein that is inhibited in the presence of bacterial endotoxin (46) . Our finding of a positive association between the acetoacetate/1,2 propanediol ratio with log IL-6 (β ± SE, 0.1 ± 0.0; p = 0.006, q = 0.12) suggests an infection-related CYP2E1 impairment in older adults with elevated IL-6.
One mechanism for counteracting infectious burden involves aryl hydrocarbon receptor (AhR) activation. AhR is involved in disease tolerance, defined as the ability of the host to reduce the effect of infection on host fitness (47) . For example, AhR activation is required for optimal resistance to Listeria monocytogenes infection (48) . Kynurenine, indoleacetate, and 3-indoxyl sulfate, metabolites that were associated with both KYN/TRYP and log IL-6, are AhR agonists (49) (50) (51) . Upon activation, AhR translocates from the cytoplasm into the nucleus, thereby initiating the transcription of CYP1A1 and CYP1A2, proteins that are involved in the detoxification of both endogenous and exogenous substrates (52, 53) . Findings for N 6 -carbamoylthreonyladenosine and bilirubin additionally suggest increased CYP1A1 expression in association with infectious burden and inflammation in older adults. Levels of N 6 -carbamoylthreonyladenosine are associated with S aureus growth (54, 55) . Staphylococcus aureus infection increases expression of CYP1A1, thereby initiating processes of detoxification and pathogen elimination (56) , in conjunction with increasing IL-6 expression (57) . Similarly, bilirubin induces CYP1A1 transcription through direct interaction with the AhR (58) . Increased AhR activation would be expected to increase levels of 1-methylurate, because CYP1A2 catalyzes the production of 1-methylurate from caffeine (59) . When considering that AhR activation increases IL-6 expression (60) and that control of bacterial and viral infections requires IL-6 (61), these data collectively suggest a role for AhR activation, CYP1A expression, and IL-6 on mechanisms related to counteracting an increased infectious burden in older adults.
Although AhR activation can increase IL-6 production, in contrast, AhR agonists can increase PPAR-α expression (62), a nuclear hormone receptor family transcription factor (63) whose activation reduces circulating IL-6 (64). One pathway that may link PPAR-α activation with decreased IL-6 may involve CYP-mediated ω-oxidation. PPAR-α activation increases expression of CYP4A11 and CYP4B1 (65, 66) , proteins that utilize ω-oxidation to convert short (C7-C9, via CYP4A) and medium chain (C10-C16, via CYP4B) fatty acids into their corresponding DC species (31) . Negative associations between adipate (C6 DC), 8-hydroxyoctanoate (C8-OH, formed during CYP4A-mediated ω-oxidation), azelate (C9 DC), sebacate (C10 DC), undecanedioate (C11 DC), and the DC/cognate fatty acid ratio for C9, C10, and C11 with log IL-6 suggests a metabolic link between PPAR-α activation and CYP-mediated ω-oxidation with decreased inflammation in older adults. Separately, although the metabolic products of CYP4A and CYP4B were negatively associated with log IL-6, in contrast, overexpression of CYP4F2 (involved in the formation of γ-CEHC from γ-tocopherol (32)) increases serum IL-6 (67). CYP4F2 transcription is inhibited upon PPAR-α activation (68) , evidence that further suggests decreased PPAR-α activation in older adults that have elevated γ-CEHC and IL-6.
Associations between 13 + 9-HODE, bilirubin, 5-oxoproline, cholesterol, glycerate, and uridine with log IL-6 provide further support for PPAR-α activation in mechanisms related to decreased inflammation in older adults. 13 + 9-HODE are direct activators of PPAR-α (69). PPAR-α activation decreases serum levels of bilirubin (70), whereas 5-oxoproline, cholesterol, and glycerate are increased (71) . The positive association identified between uridine and log IL-6 may be related to its protective effect in the presence of elevated PPAR-α. In support of this, high-dose PPAR-α agonism induces hepatic microvesicular steatosis (72) , an effect that is prevented with uridine supplementation (73) .
Study Limitations
Our study has certain limitations. First, our cohort included older adults at-risk for mobility disability (Short Physical Performance Battery Score < 10)-whether the identified associations are found in higher-functioning older adults is currently unknown. Second, although predictive modeling identified a combination of metabolites that explains 51% of the variability in log IL-6, because of our relatively small sample size (N = 73), validation of these results in a larger cohort is necessary. Third, because this was an associationbased study, causality between circulating metabolites with serum IL-6 levels cannot be inferred. Lastly, our findings represent a single time-point snapshot of systemic metabolism. Accordingly, studies aimed at identifying metabolites associated with longitudinal changes in inflammatory markers will be important for further elucidating mechanisms related to inflammation in older adults.
Conclusions
With the goal of developing an improved understanding about mechanisms that may underlie inflammation in older adults, in the current study we used a metabolomic approach to identify significant associations between serum metabolites with circulating IL-6. Our findings suggest important roles for tryptophan metabolism, infectious burden, activation of host defense, and detoxification through CYP-mediated pathways in mechanisms related to increased IL-6, whereas CYP-mediated ω-oxidation and PPAR-α activation may be involved in mechanisms related to decreased IL-6. Collectively, these data suggest that future studies aimed at decreasing infectious burden, or increasing PPAR-α activation may be a targeted means for decreasing circulating IL-6 in older adults. 
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